SINDAN
3 articole · RSS
Health
Teva’s Sindan Pharma Revenue Reaches RON160M in 2019
Israeli Teva group owned Sindan Pharma pharmaceutical plant in Bucharest posted 160 million lei revenue in 2019, an increase of RON64 million on the previous year, Finance Ministry data show.
Health
Dan Ivan, Actavis: We Thoroughly Changed Our Business Model
Retail sales (via pharmacies) are now at more than 60% of the total at the moment, because of a decision made to change the business model at the end of 2011, says Dan Ivan, general manager...
Health
Romania Remains Core Of Cancer Drug Business For Actavis
Claudio Albrecht, CEO of Actavis drug maker, with EUR1.7 billion in turnover in 2010, which owns Sindan plant in Romania, says a Swiss or an Austrian would not have the same results as the R...